1-4 of 4
Katherine Karakasis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials

Michelle McMullen, Katherine Karakasis, Amit M. Oza
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5271–5273.
https://doi.org/10.1158/1078-0432.CCR-20-2429
Published: 15 October 2020
View article titled, Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials
Open the PDF for Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials in another window
Journal Articles

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Stephanie Lheureux, Ana Oaknin, Swati Garg, Jeffrey P. Bruce, Ainhoa Madariaga, Neesha C. Dhani, Valerie Bowering, Justin White, Sarah Accardi, Qian Tan, Marsela Braunstein, Katherine Karakasis, Iulia Cirlan, Stephanie Pedersen, Tiantiam Li, Lorena Fariñas-Madrid, Yeh Chen Lee, Zhihui (Amy) Liu, Trevor J. Pugh, Amit M. Oza
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (16): 4206–4215.
https://doi.org/10.1158/1078-0432.CCR-19-4121
Published: 14 August 2020
View article titled, EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Open the PDF for EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression in another window
Includes: Supplementary data
Journal Articles

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization

Stephanie Lheureux, Zhongwu Lai, Brian A. Dougherty, Sarah Runswick, Darren R. Hodgson, Kirsten M. Timms, Jerry S. Lanchbury, Stan Kaye, Charlie Gourley, David Bowtell, Elise C. Kohn, Claire Scott, Ursula Matulonis, Tony Panzarella, Katherine Karakasis, Julia V. Burnier, C. Blake Gilks, Mark J. O'Connor, Jane D. Robertson, Jonathan Ledermann, J. Carl Barrett, Tony W. Ho, Amit M. Oza
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4086–4094.
https://doi.org/10.1158/1078-0432.CCR-16-2615
Published: 01 August 2017
View article titled, Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization
Open the PDF for Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization in another window
Includes: Supplementary data
Journal Articles

Abstract A35: Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.

Stephanie Lheureux, Cindy Yang, Patricia Shaw, Blaise Clarke, Julissa Tsao, Katherine Karakasis, Marcus Butler, Noor Salman, Mark Dowar, Jing Xu, Laurent Poulain, Pamela S. Ohashi, Trevor Pugh, Amit Oza
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A35.
https://doi.org/10.1158/1557-3265.OVCA15-A35
Published: 15 January 2016
View article titled, Abstract A35: Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.